Ignite Creation Date:
2024-07-17 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497517
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-05
Brief Title:
A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Phase 1 Single Center Single Dose Open-Label Randomized 2-Way Crossover Study to Investigate the Food Effect on the Pharmacokinetics of Camlipixant in Healthy Male and Female Participants
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a single center single dose open-label randomly assigned 2-way crossover study The study will investigate the food effect on the pharmacokinetics of Camlipixant GSK5464714 in healthy male and female participants Eligible participants will be randomized to pre-defined sequences There will be a washout of minimum 7 days between each dose of treatment period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None